AU2001281979A1 - Matrix controlled transdermal system for stabile derivatives of ace inhibitors - Google Patents

Matrix controlled transdermal system for stabile derivatives of ace inhibitors

Info

Publication number
AU2001281979A1
AU2001281979A1 AU2001281979A AU2001281979A AU2001281979A1 AU 2001281979 A1 AU2001281979 A1 AU 2001281979A1 AU 2001281979 A AU2001281979 A AU 2001281979A AU 2001281979 A AU2001281979 A AU 2001281979A AU 2001281979 A1 AU2001281979 A1 AU 2001281979A1
Authority
AU
Australia
Prior art keywords
stabile
derivatives
ace inhibitors
transdermal system
matrix controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001281979A
Other versions
AU2001281979B2 (en
Inventor
Wilfried Fischer
Karin Klokkers
Kai-Thomas Kramer
Anna Sendl-Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10033855A external-priority patent/DE10033855A1/en
Application filed by Hexal AG filed Critical Hexal AG
Publication of AU2001281979A1 publication Critical patent/AU2001281979A1/en
Application granted granted Critical
Publication of AU2001281979B2 publication Critical patent/AU2001281979B2/en
Priority to AU2007201226A priority Critical patent/AU2007201226B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001281979A 2000-07-12 2001-07-12 Matrix controlled transdermal system for stabile derivatives of ace inhibitors Ceased AU2001281979B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2007201226A AU2007201226B2 (en) 2000-07-12 2007-03-21 Matrix-controlled transdermal system for stable derivatives of ACE inhibitors

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10033855A DE10033855A1 (en) 2000-07-12 2000-07-12 Transdermal therapeutic system for long-term treatment of hypertension, containing dicarboxylic acid angiotensin converting enzyme inhibitor converted into salt or ester derivative to improve stability
DE10033855.0 2000-07-12
PCT/EP2001/008071 WO2002003970A2 (en) 2000-07-12 2001-07-12 Matrix controlled transdermal system for stabile derivatives of ace inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2007201226A Division AU2007201226B2 (en) 2000-07-12 2007-03-21 Matrix-controlled transdermal system for stable derivatives of ACE inhibitors

Publications (2)

Publication Number Publication Date
AU2001281979A1 true AU2001281979A1 (en) 2002-04-18
AU2001281979B2 AU2001281979B2 (en) 2006-12-21

Family

ID=7648664

Family Applications (3)

Application Number Title Priority Date Filing Date
AU8197901A Pending AU8197901A (en) 2000-07-12 2001-07-12 Matrix controlled transdermal system for stabile derivatives of ace inhibitors
AU2001281979A Ceased AU2001281979B2 (en) 2000-07-12 2001-07-12 Matrix controlled transdermal system for stabile derivatives of ace inhibitors
AU2007201226A Ceased AU2007201226B2 (en) 2000-07-12 2007-03-21 Matrix-controlled transdermal system for stable derivatives of ACE inhibitors

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU8197901A Pending AU8197901A (en) 2000-07-12 2001-07-12 Matrix controlled transdermal system for stabile derivatives of ace inhibitors

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2007201226A Ceased AU2007201226B2 (en) 2000-07-12 2007-03-21 Matrix-controlled transdermal system for stable derivatives of ACE inhibitors

Country Status (8)

Country Link
US (1) US20040052835A1 (en)
EP (2) EP1792611A1 (en)
JP (1) JP2004502726A (en)
AT (1) ATE342052T1 (en)
AU (3) AU8197901A (en)
CA (1) CA2415476C (en)
DE (2) DE10033855A1 (en)
WO (1) WO2002003970A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1406633T3 (en) 2001-06-18 2011-10-31 Noven Pharma Improved drug delivery in transdermal systems
DE10137405A1 (en) * 2001-07-31 2003-02-20 Beiersdorf Ag Drug-containing self-adhesive composition production, e.g. for use in plasters, from styrene block copolymer by continuous, solvent-free and mastication-free process based on extrusion
US6805878B2 (en) 2001-09-13 2004-10-19 Noven Pharmaceuticals, Inc. Transdermal administration of ACE inhibitors
US20050191339A1 (en) * 2002-08-08 2005-09-01 Beiersdorf Ag Skin friendly active ingredient plaster based on SBC, containing at least 34 WT.% of a pharmaceutical active ingredient and production thereof
DE10236319A1 (en) * 2002-08-08 2004-02-19 Beiersdorf Ag Active agent containing matrix plaster for the controlled delivery of an active agent to the skin comprises a pharmaceutical active agent containing a water insoluble adhesive matrix comprising a styrene block copolymer
KR20070072867A (en) * 2004-09-01 2007-07-06 넥스메드 홀딩스 인코포레이티드 Transdermal antiemesis delivery system, method and composition therefor
ITMI20050949A1 (en) * 2005-05-24 2006-11-25 Dipharma Spa CRYSTAL FORM OF FOSINOPRIL CALCIUM
DE102005058166A1 (en) 2005-12-05 2007-06-06 Hexal Ag Matrix-controlled transdermal system with amine salts of ACE inhibitor dicarboxylic acids
US7943655B2 (en) * 2006-04-05 2011-05-17 Universitat Zurich Polymorphic and pseudopolymorphic forms of trandolaprilat, pharmaceutical compositions and methods for production and use
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
US20090269390A1 (en) * 2008-04-25 2009-10-29 Medtronic, Inc. Medical devices, polymers, compositions, and methods for delivering a haloacetate
EP2537534B1 (en) * 2011-06-22 2014-12-17 Hexal AG Esters of (1S,9S)-9-[[(1S)-1-carboxy-3-phenylpropyl]amino]octahydro-10-oxo-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid and their therapeutic use.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE107517T1 (en) * 1989-05-25 1994-07-15 Takeda Chemical Industries Ltd TRANSDERMAL THERAPEUTIC AGENT.
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
JP2849937B2 (en) * 1990-04-18 1999-01-27 日東電工株式会社 Medical patch
WO1994001093A1 (en) * 1992-07-09 1994-01-20 Merck & Co., Inc. Controlled porosity osmotic enalapril pump
JPH0840896A (en) * 1994-08-04 1996-02-13 Teisan Seiyaku Kk Medical preparation composed of captopril analogue
DE19512181C2 (en) * 1995-03-31 2003-11-06 Hexal Pharma Gmbh Transdermal system with ramipril and / or trandolapril as an ACE inhibitor
DE19728517C2 (en) * 1997-07-04 1999-11-11 Sanol Arznei Schwarz Gmbh TTS for the administration of sex steroid hormones and process for its preparation
DE29823343U1 (en) * 1998-03-20 1999-07-15 Sanol Arznei Schwarz Gmbh Transdermal therapeutic system (TTS) containing oxybutynin
DE19821788C1 (en) * 1998-05-15 1999-12-02 Sanol Arznei Schwarz Gmbh Transdermal therapeutic system (TTS) containing pergolide

Similar Documents

Publication Publication Date Title
AU2001281979A1 (en) Matrix controlled transdermal system for stabile derivatives of ace inhibitors
AU2001232036A1 (en) Pyrimidine derivatives as selective inhibitors of cox-2
AU6111000A (en) Inhibitors of viral helcase
AU2978400A (en) Method of manufacture for transdermal matrices
AU2001243158A1 (en) Inhibitors of prenyl-protein transferase
AU2002210463A1 (en) Transdermal therapeutic system
AU4201799A (en) Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
AU2003250469A1 (en) Isoquinoline derivatives as matrix metalloproteinase inhibitors
AU3929600A (en) Matrix metalloproteinase inhibitors and method of using same
AU7354900A (en) Inhibitors of prenyl-protein transferase
AU2001238217A1 (en) Inhibitors of prenyl-protein transferase
AU2001247197A1 (en) Inhibitors of prenyl-protein transferase
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU1036601A (en) Method of screening for inhibitors of asp1
AU2001227757A1 (en) Inhibitors of prenyl-protein transferase
AU2274101A (en) Inhibitors of prenyl-protein transferase
AU2001238424A1 (en) Inhibitors of prenyl-protein transferase
AU2001230864A1 (en) Inhibitors of prenyl-protein transferase
AU2001255408A1 (en) Tetrahydro-azepinone derivatives as thrombin inhibitors
AU8005100A (en) Inhibitors of neuraminidases
AU2001229320A1 (en) Inhibitors of prenyl-protein transferase
AU4279900A (en) Method for determining plasminogen activator inhibitor
AU2001270131A1 (en) Screen for identifying inhibitors of glycosylphosphatidylnositol anchoring
AU2001227756A1 (en) Inhibitors of prenyl-protein transferase
AU2001284469A1 (en) Methods for crystallization of hydroxycarboxylic acids